[Paraneoplastic hypoglycemia in liver-cell carcinoma. Nadler Wolfer Elliott syndrome].
D000328:Adult; D001761:Bleomycin / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy / Q000209:etiology*; D008113:Liver Neoplasms / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009362:Neoplasm Metastasis; D013311:Streptozocin / Q000627:therapeutic use; D013577:Syndrome
D001761:Bleomycin; D013311:Streptozocin; D003520:Cyclophosphamide; D005947:Glucose
Paraneoplastiche Hypoglykämie bei Leberzelkarzinom. Kassuistischer Beitrag zum Nadler-Wolfer-Elliott-Syndrom.